Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.
about
Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatmentMechanisms of immune evasion and current status of checkpoint inhibitors in non-small cell lung cancerEmerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasisTargeted immunotherapy for non-small cell lung cancer.The Treg/Th17 paradigm in lung cancerSelective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancerIdentification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors.Immune reconstitution from peripheral blood mononuclear cells inhibits lung carcinoma growth in NOD/SCID miceMetastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.Enhancing Dendritic Cell-based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established Tumors.Nanoscale Relationship Between CD4 and CD25 of T Cells Visualized with NSOM/QD-Based Dual-Color Imaging SystemEffects of etomidate and propofol on immune function in patients with lung adenocarcinoma.B cell regulation of anti-tumor immune response.The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcomeBone metastases in lung cancer. Potential novel approaches to therapy.Human lung tumor FOXP3+ Tregs upregulate four "Treg-locking" transcription factors.Immune Checkpoint Inhibitor Therapy: What Line of Therapy and How to Choose?Immune checkpoint therapy for non-small-cell lung cancer: an update.Regulatory T cells in oral squamous cell carcinoma.IL-17 induces radiation resistance of B lymphoma cells by suppressing p53 expression and thereby inhibiting irradiation-triggered apoptosis.Human tumor infiltrating lymphocytes cooperatively regulate prostate tumor growth in a humanized mouse model.Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responsesCytokine-induced killer cell therapy for modulating regulatory T cells in patients with non-small cell lung cancerTumor lymphocytic infiltration in non-small cell lung cancer: the ultimate prognostic marker?Lung Cancer Subtypes Generate Unique Immune Responses.The paradoxical role of tumor-infiltrating immune cells in lung cancer.CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells.The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma.[Advances of the relationship between leptin system and non-small cell lung cancer].Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer.The functional verification of EGFR-CAR T-cells targeted to hypopharyngeal squamous cell carcinoma
P2860
Q26738359-A1028BE9-5882-4F28-9E73-C9B4AD77433AQ26740288-E4845D18-8A98-41E9-AE19-64DBB02C573AQ28069422-AB9A1646-BA38-4B50-8C32-0865FD21DB9BQ33585089-D3D24FB5-7915-4638-A3FF-2B6F36FC2876Q33608606-7BF34E52-9B96-4EAD-AB6A-6142D8BDA39CQ33608626-FE47BF09-8D4D-4068-89E5-F22A9D3C9C19Q33958457-0A991870-7ECC-4CDD-AD0F-3BB23D192FFEQ34141837-471FD734-857F-4A62-9E84-5248DB93D72BQ34417878-154675D7-4A50-4FC8-9510-2C1F1ADE30CDQ36177023-C59B2FD6-A50A-4414-B36A-71DDF9AC7104Q36211172-990FD5AF-3080-4950-B1C9-7EAE33705860Q37553902-F6F3ACD5-7F2D-40B2-B70E-DEFAA4E999AAQ38167668-A9C28541-AB9E-447D-8825-0DC1AFC410B5Q38264982-A1CA92DF-A98B-4F9A-B7D7-4B1DD0435A93Q38541387-69C0F426-6948-4D18-828E-EE36732F3E8EQ38621446-9A0F2287-F598-4A33-A453-4C701B2036F7Q38680348-7856E6EB-33F9-4217-B236-CF6BF41AF2AFQ38727542-EE4A9AD1-A6C6-48AD-87D4-C3A0F237BDE6Q38809637-8F4EB565-9B72-4319-9630-201DA964719FQ38924976-E4016818-E354-425E-A847-C08309C4CC63Q39827098-D5D0F243-6A6E-43A0-91CD-95EEDF5032CCQ40982736-32F37251-A512-446F-98C1-1F42E2C191E9Q41016369-6B9BBBF4-DD9D-4384-9F87-A1E6FB89FAEEQ42398706-3E64FD57-ED38-4199-9B08-0FBEC15C329EQ45459148-8E96EB82-8A9B-4CD9-B1BC-BFBE5297EF81Q47103744-BD2F33E4-0727-4FE5-A4D4-0F26300CF9C4Q47307445-24FC6943-0E2B-4B3B-A14D-B22AA66D213DQ55456844-56226C92-7370-45CD-9937-60483AAEAA51Q55464236-48F5687E-A73A-4941-B416-246A428A4859Q55473534-F422379E-DB85-4049-AD35-7F4A1EAF6DB4Q58558222-3B5DD282-F406-4201-A83E-96596B8396BF
P2860
Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-infiltrating regulatory ...... ponses to lung adenocarcinoma.
@en
Tumor-infiltrating regulatory ...... ponses to lung adenocarcinoma.
@nl
type
label
Tumor-infiltrating regulatory ...... ponses to lung adenocarcinoma.
@en
Tumor-infiltrating regulatory ...... ponses to lung adenocarcinoma.
@nl
prefLabel
Tumor-infiltrating regulatory ...... ponses to lung adenocarcinoma.
@en
Tumor-infiltrating regulatory ...... ponses to lung adenocarcinoma.
@nl
P2093
P2860
P356
P1476
Tumor-infiltrating regulatory ...... ponses to lung adenocarcinoma.
@en
P2093
Adam Yagui-Beltrán
Anusha-Preethi Ganesan
Brian Ruffell
David M Jablons
Jonathan Lau
Lisa M Coussens
Magnus Johansson
P2860
P304
P356
10.4049/JIMMUNOL.1301317
P407
P577
2013-07-12T00:00:00Z